A carregar...

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

The incidence of breast cancer brain metastases has increased in recent years, largely due to improved control of systemic disease with human epidermal growth factor receptor 2 (HER2)-targeted agents and the inability of most of these agents to efficiently cross the blood–blood barrier (BBB) and con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peddi, Parvin F., Hurvitz, Sara A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3980725/
https://ncbi.nlm.nih.gov/pubmed/24469856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-014-1369-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!